Announce Date | 07/29/2025 |
EPS Normalized Actual | $2.58 (Beat by $0.28) |
EPS GAAP Actual | $2.58 (Beat by $0.28) |
Revenue Actual | $0B |
Revenue Surprise | Beat by $0M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.34881 |
EPS GAAP Estimate | $2.34881 |
Revenue Estimate | $4.403063373B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 9.85 | 9 | 9.33536 | 10.56683 | 1 |
Dec 2027 | 9.33 | 9.5 | 8.84253 | 10.00899 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0 | -2.27161 | 0B | -INF% | -4187.32M |
FQ1 2025 (Mar 2025) | 1.51 | 1.51 | 4.673B | 17.78% | 4673M |
FQ4 2024 (Dec 2024) | 2.48 | 2.48 | 4.51B | 14.12% | 4510M |
FQ3 2024 (Sep 2024) | 2.58 | 2.58 | 4.551B | 27.66% | 4551M |
FQ2 2024 (Jun 2024) | 3.4 | 3.4 | 4.062B | 23.98% | 4062M |
FQ1 2024 (Mar 2024) | 3.02 | 3.02 | 3.842B | 19.26% | 3842M |
FQ4 2023 (Dec 2023) | 6.15 | 6.15 | 3.873B | 23.82% | 3873M |
FQ3 2023 (Sep 2023) | 1.93 | 1.93 | 3.292B | 27.51% | 3292M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.34881
Consensus Revenue Estimates
4.403063373B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.80198 | -- | 2.4968 | 3.00553 | 4 |
FQ3 2027 (Sep 2027) | 1.90988 | -- | 1.70186 | 2.04862 | 3 |
FQ2 2027 (Jun 2027) | 3.05233 | -- | 2.71988 | 3.27406 | 4 |
FQ1 2027 (Mar 2027) | 2.93147 | -- | 2.61218 | 3.14442 | 3 |
FQ4 2026 (Oct 2026) | 1.64495 | -- | 1.55664 | 1.72422 | 3 |
FQ3 2026 (Jul 2026) | 2.5338 | -- | 2.39777 | 2.6559 | 3 |
FQ2 2026 (Jun 2026) | 2.44465 | -- | 2.36978 | 2.56768 | 3 |
FQ1 2026 (Mar 2026) | 2.36695 | 36.2 | 2.29446 | 2.48607 | 6 |
FQ4 2025 (Oct 2025) | 1.7308 | -43.29 | 1.63788 | 1.8142 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.47B | -- | 4.1B | 4.72B | 4 |
FQ3 2027 (Sep 2027) | 4.88B | -- | 4.47B | 5.16B | 4 |
FQ2 2027 (Jun 2027) | 5B | -- | 4.58B | 5.28B | 4 |
FQ1 2027 (Mar 2027) | 5.54B | -- | 5.08B | 5.85B | 4 |
FQ4 2026 (Oct 2026) | 4.3B | -- | 4.12B | 4.45B | 2 |
FQ3 2026 (Jul 2026) | 4.87B | -- | 4.67B | 5.05B | 2 |
FQ2 2026 (Jun 2026) | 4.1B | -- | 4B | 4.26B | 2 |
FQ1 2026 (Mar 2026) | 4.03B | -15.91 | 3.94B | 4.19B | 2 |
FQ4 2025 (Oct 2025) | 4.19B | -7.59 | 4.02B | 4.35B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.27161 | 0 | -2.27161 | -INF% |
FQ1 2025 (Mar 2025) | 1.51 | 1.51 | 100% | |
FQ4 2024 (Dec 2024) | 2.48 | 2.48 | 100% | |
FQ3 2024 (Sep 2024) | 2.58 | 2.58 | 100% | |
FQ2 2024 (Jun 2024) | 3.4 | 3.4 | 100% | |
FQ1 2024 (Mar 2024) | 3.02 | 3.02 | 100% | |
FQ4 2023 (Dec 2023) | 6.15 | 6.15 | 100% | |
FQ3 2023 (Sep 2023) | 1.93 | 1.93 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $4.19B | $0B | $-4187.32M | -INF% |
FQ1 2025 (Mar 2025) | $0B | $4.67B | $4673M | 100% |
FQ4 2024 (Dec 2024) | $0B | $4.51B | $4510M | 100% |
FQ3 2024 (Sep 2024) | $0B | $4.55B | $4551M | 100% |
FQ2 2024 (Jun 2024) | $0B | $4.06B | $4062M | 100% |
FQ1 2024 (Mar 2024) | $0B | $3.84B | $3842M | 100% |
FQ4 2023 (Dec 2023) | $0B | $3.87B | $3873M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.29B | $3292M | 100% |